DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Alphagan P (Brimonidine Ophthalmic) - Adverse Event Reports - All Cases

 



Index of reports > All cases (8)

     Drug Ineffective (3)Visual Field Defect (2)Intraocular Pressure Increased (2)Visual Acuity Reduced (2)Vision Blurred (2)Corneal Oedema (2)Cataract (1)Palpitations (1)Eye Operation Complication (1)Renal Failure Acute (1)

Below is the selection of adverse event reports related to Alphagan P (Brimonidine Ophthalmic) that includes all cases.

Adverse event in male receiving Alphagan P (Brimonidine Ophthalmic)

Reported by a individual with unspecified qualification from United States on 2007-10-09

Patient: male, weighing 93.0 kg (204.6 pounds)

Adverse reactions / side effects: Astigmatism, Drug Ineffective, Coma, Photopsia, Diplopia, Vitreous Floaters, Photophobia, Glare, Eye Operation Complication, Depression, Crying, Cataract, Mydriasis, Visual Field Defect, Partner Stress, Social Problem, Loss of Employment, Activities of Daily Living Impaired, Mental Disorder, DRY Eye

Suspect drug(s):
Pilocarpine
    Dosage: 4 drops daily occlusive dressing
    Indication: Pupillary Disorder
    Start date: 2004-10-15
    End date: 2007-07-03

Alphagan P
    Dosage: 4 drops daily occlusive dressing
    Indication: Pupillary Disorder
    Start date: 2004-10-15
    End date: 2007-10-06



Adverse event in female receiving Alphagan P (Brimonidine Ophthalmic)

Reported by a individual with unspecified qualification from United States on 2007-06-12

Patient: female, weighing 56.7 kg (124.7 pounds)

Adverse reactions / side effects: Tinnitus, Palpitations, Sensation of Pressure, Feeling Abnormal, Hypertension

Suspect drug(s):
Alphagan P (Brimonidine Ophthalmic)



Adverse event in male receiving Alphagan P (Brimonidine Ophthalmic)

Reported by a physician from United States on 2007-06-04

Patient: male, weighing 97.5 kg (214.5 pounds)

Adverse reactions / side effects: Blood Creatinine Increased

Suspect drug(s):
Alphagan P (Brimonidine Ophthalmic)

Other drugs received by patient: Coumadin; Glucotrol; Lisinopril; Lantus; Bumex; Advair Diskus 100 / 50



Adverse event in male receiving Alphagan P (Brimonidine Ophthalmic)

Reported by a physician from United States on 2007-05-08

Patient: male

Adverse reactions / side effects: Renal Failure Acute

Suspect drug(s):
Alphagan P (Brimonidine Ophthalmic)

Other drugs received by patient: Coumadin; Glucotrol; Lisinopril; Lantus; Bumex; Advair Diskus 100 / 50



Adverse event in 86 year old male receiving Alphagan P (Brimonidine Ophthalmic)

Reported by a physician from United States on 2007-04-26

Patient: 86 year old male, weighing 68.3 kg (150.3 pounds)

Adverse reactions / side effects: Pupillary Reflex Impaired, Eye Irritation, Visual Field Defect, Corneal Scar, Documented Hypersensitivity TO Administered Drug, Drug Hypersensitivity, Ocular Hyperaemia

Suspect drug(s):
Alphagan P
    Dosage: 1 drop ou q 8 hours
    Indication: Glaucoma
    Start date: 2006-09-22
    End date: 2006-12-12

Alphagan
    Dosage: 1 drop ou q 12 hours
    Indication: Glaucoma
    Start date: 2001-09-03
    End date: 2002-09-12

Other drugs received by patient: Cosopt; Travatan; Aspirin; Terazosin HCL; Simvastatin; Levalbuterol Tart; Ipratropium BR; Flunisolide; Colchicine; Brimonidine Tartrate; Meclizine



Adverse event in 26 year old female receiving Alphagan P (Brimonidine Ophthalmic)

Reported by a physician from Korea, Republic of on 2007-02-14

Patient: 26 year old female

Adverse reactions / side effects: Drug Ineffective, Intraocular Pressure Increased, Vision Blurred, Retinal Disorder, Optic Nerve CUP / Disc Ratio Increased, Condition Aggravated, Visual Acuity Reduced, Corneal Oedema

Adverse event resulted in: hospitalization

Suspect drug(s):
Cosopt
    Dosage: unk opht
    Indication: Developmental Glaucoma

Cosopt
    Dosage: unk opht
    Indication: Open Angle Glaucoma

Alphagan P
    Dosage: unk opht
    Indication: Developmental Glaucoma

Alphagan P
    Dosage: unk opht
    Indication: Open Angle Glaucoma

Xalatan
    Dosage: unk opht
    Indication: Developmental Glaucoma

Xalatan
    Dosage: unk opht
    Indication: Open Angle Glaucoma



Adverse event in 85 year old female receiving Alphagan P (Brimonidine Ophthalmic)

Reported by a physician from United States on 2007-02-07

Patient: 85 year old female

Adverse reactions / side effects: Death

Adverse event resulted in: death

Suspect drug(s):
Alphagan P
    Dosage: unk, bid
    Indication: Glaucoma
    Start date: 2006-10-06
    End date: 2007-01-22

Lumigan
    Indication: Glaucoma
    Start date: 2006-10-06
    End date: 2007-01-22



Adverse event in 26 year old female receiving Alphagan P (Brimonidine Ophthalmic)

Reported by a physician from Korea, Republic of on 2007-02-06

Patient: 26 year old female

Adverse reactions / side effects: Drug Ineffective, Intraocular Pressure Increased, Vision Blurred, Visual Acuity Reduced, Corneal Oedema

Adverse event resulted in: hospitalization

Suspect drug(s):
Cosopt
    Dosage: opht
    Indication: Developmental Glaucoma

Cosopt
    Dosage: opht
    Indication: Open Angle Glaucoma

Alphagan P
    Dosage: opht
    Indication: Developmental Glaucoma

Alphagan P
    Dosage: opht
    Indication: Open Angle Glaucoma

Xalatan
    Dosage: opht
    Indication: Developmental Glaucoma

Xalatan
    Dosage: opht
    Indication: Open Angle Glaucoma

-- advertisement -- The American Red Cross
We comply with
HONcode standard.
Verify here.
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2009